The growing importance of real-world data in life sciences research
Life sciences research has traditionally relied heavily on controlled clinical trials to understand the safety and effectiveness of new treatments. While clinical trials remain essential, they cannot always show exactly how a therapy will perform once it reaches a broader patient population. This is where real-world data is becoming increasingly valuable.
Real-world data can provide researchers with information about patients, treatments, outcomes, and healthcare experiences outside conventional clinical trial environments. As technology makes it easier to collect and analyze large amounts of health information, these insights are becoming an increasingly important part of research and evidence generation.
What Is Real-World Data?
Real-world data refers to health-related information collected through sources outside traditional randomized clinical trials. It can come from electronic health records, insurance claims, patient registries, disease databases, wearable devices, and other sources generated during routine healthcare.
Researchers can analyze this information to produce real-world evidence about how medical products and interventions perform in everyday clinical practice. Rather than replacing controlled research, real-world data can complement it by providing a broader view of treatment use and patient experiences.
Understanding Patients Beyond Clinical Trials
Clinical trials generally operate according to carefully designed protocols and specific eligibility requirements. These controls are necessary for answering important research questions, but trial populations may not fully represent the patients who eventually receive a treatment.
Real-world data can help researchers study larger and more varied patient groups. It may provide information about people of different ages, patients with multiple health conditions, and individuals receiving treatments in different healthcare environments.
These insights can help life sciences organizations develop a more complete understanding of how diseases and treatments affect patients in routine practice.
Supporting Research Throughout the Product Life Cycle
The potential applications of real-world data extend across multiple stages of a medical product’s life cycle. During development, researchers may use existing data to better understand disease progression, patient populations, treatment patterns, and unmet needs.
After a therapy becomes available, real-world evidence can contribute to research into longer-term outcomes, treatment utilization, safety, and effectiveness. Organizations seeking specialist support with these activities may work with real-world evidence experts such as cytel to develop appropriate research and analytical approaches.
This ability to generate evidence beyond the boundaries of an individual clinical trial can support ongoing learning about a treatment throughout its use.
Making Better Use of Expanding Health Data
The growth of digital healthcare has significantly increased the amount of information potentially available to researchers. Electronic health records have become widespread, while digital health technologies and connected devices can generate additional information about patients outside traditional clinical settings.
However, having access to large quantities of data does not automatically produce useful evidence. Data quality, completeness, relevance, and consistency all matter. Researchers also need suitable statistical methods and clearly defined research questions to ensure that analyses generate meaningful findings.
As a result, expertise in data management, study design, and advanced analytics is becoming increasingly important alongside access to real-world information.
Complementing Traditional Clinical Evidence
Real-world data and randomized clinical trials should not necessarily be viewed as competing approaches. Each can answer different types of research questions.
Clinical trials provide controlled environments designed to evaluate specific hypotheses while reducing potential sources of bias. Real-world studies can offer insights into what happens when treatments are used across broader populations and routine healthcare environments.
Using these evidence sources together can create a more detailed picture of a treatment, disease, or patient population than relying on either approach alone.
A Growing Role in Life Sciences Research
As healthcare becomes more data-driven, the role of real-world data is likely to continue expanding. Life sciences organizations increasingly have opportunities to study patient experiences, treatment patterns, and outcomes using information generated through everyday healthcare.
The challenge is not simply collecting more data, but turning appropriate data into reliable and relevant evidence. When supported by careful study design and robust analytical methods, real-world data can complement traditional research and contribute to a deeper understanding of treatments and the patients who use them.
